ASTH — Astrana Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual income statement for Astrana Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	774	1,144	1,387	2,035	3,182
Cost of Revenue
Gross Profit	178	199	215	271	342
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	686	1,061	1,307	1,944	3,103
Operating Profit	87.4	83	80	90.1	78.5
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	77.7	86.6	89.8	80.8	39.6
Provision for Income Taxes
Net Income After Taxes	46.1	45.7	57.8	49.9	24.1
Minority Interest
Net Income Before Extraordinary Items
Net Income	68.9	45.2	60.7	43.1	22.5
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	68.9	45.2	60.7	43.1	22.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.66	1.24	1.36	0.89	0.935